![]() |
|
|
Healthcare Research Institute, Wakunaga Pharmaceutical, Company, Koda-cho, Akitakata, Hiroshima 739-1195, Japan
3 To whom correspondence should be addressed. E-mail: moriguchi_tr{at}wakunaga.co.jp.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: hypertension aged garlic extract rat
Lifestyle-related diseases, such as diabetes, hyperlipemia, and hypertension, pose a serious issue in Japan's aging society due to Westernization of the diet. The phrase lifestyle-related disease has been used instead of adult disease since 1996. This terminology represents a concept for a group of diseases in which symptomatic appearance and progress are affected by living practices that include eating, exercising, rest, smoking, and drinking. The Ministry of Health and Welfare of Japan has been conducting Healthy Japan 21, a 10-year national health effort that began in 2000 to improve lifestyle-related diseases including hypertension. Hypertension, a typical lifestyle-related disease, has been considered the most important risk factor for chronic circulatory organ disease (1). The total number of hypertensive patients in Japan are estimated at 7 million or more (2). Moreover, it is estimated that there may be
65 million hypertensive people in the United States (3). Recently, many medical supplies and health foods have been researched and developed to prevent or improve hypertension.
Garlic has been used as a traditional medicine in both chronic and acute diseases for more than 1000 years. Aged garlic extract (AGE),4 extracted for a period of >10 mo, is less irritating and does not produce the harmful aftereffects of raw garlic (3). This observation is advantageous for long-term administration to prevent or treat chronic disease. In the circulatory system, AGE and its components have been shown to improve peripheral circulation (4), protect vascular endothelial cells from oxidant injury (57), and reduce plasma lipid concentration (8,9).
We investigated differences in the blood-pressure (BP)lowering effects of AGE and raw garlic (RG) in hypertensive rats.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Preparation of garlic source and experimental diet.
AGE was prepared by Wakunaga Pharmaceutical Co. To prepare it, sliced raw garlic cloves were soaked in aqueous ethanol for >10 mo in stainless-steel tanks at room temperature, then AGE was concentrated to
50% as solid-material content and dried with a spray dryer (Pulvis GB22, Yamato Scientific).
RG was purchased from a local market. Garlic skin was peeled and cloves were sliced into 23 pieces. Sliced garlic was lyophilized using a freeze dryer (FRD 50P, Iwaki Glass) and was pulverized into fine powder using a laboratory blender (Waring). These powders were stored at 4°C before making the experimental diet. AGE and RG powder were used in place of a portion of cellulose and were added to the AIN93G powder diet to make an equal amount of water-soluble extract (Table 1).
|
Statistical analysis. All data were expressed as means ± SEM and were analyzed using the STATISTICA program (Statsoft Japan Inc.). The differences between the control and experimental diet groups were analyzed by one-way or two-way ANOVA followed by Tukey's honestly significant difference test. The curves were fit to the data for Figures 1 and 2 with regression analysis using the Sigma Plot program (Hulinks).
|
|
| RESULTS |
|---|
|
|
|---|
|
34 wk after the beginning of the experimental diet feeding (Fig. 1). These lowering effects were significantly different compared with the control group [F(2, 24) = 7.179, P < 0.01; AGE, P < 0.05; RG, P < 0.01]. There was no significant difference between the two garlic-fed groups, although the effect of RG appeared greater than that of AGE (P = 0.472). The MBP of the RG group was significantly lower than that of the control group, although the AGE group was not different from the control group [Fig. 2, F(2, 24) = 4.725, P < 0.05; AGE, P = 0.939; RG, P < 0.05]. In the PP, which was computed from the SBP and the MBP, only the AGE group showed a lowering effect, but there was no difference in the RG group when compared with the control group [Fig. 3, F(2, 24) = 6.754, P < 0.01; AGE, P < 0.01; RG, P = 0.06]. The heart rate, which was simultaneously measured during the measurement of the SBP and the MBP, was not different among the groups [data not shown, F(2, 24) = 0.013, P = 0.99].
|
|
In the stomach, many polyps were found in the forestomach of the RG group, although there were no changes of the forestomach in either the control and the AGE groups. The rate of polyp generation in the RG group was 78% (7 of 9 animals). In the histological view, intense hypertrophy of the squamous epithelium layer was observed, although there were no abnormalities observed in the keratin layer or the tunica muscularis. These polyps were judged benign papilloma, considering the nature of the cell division in the squamous epithelium layer of the stomach (Fig. 4).
| DISCUSSION |
|---|
|
|
|---|
PP calculated from SBP and MBP gradually increases with aging and is used as an index of heart function and artery extensibility in the circulatory system (21,22). In the fractional analysis of the blood pressure, AGE showed a lowering of the PP, only by reducing SBP and without affecting the MBP, as compared with the control group. This result suggests that chronic feeding of AGE improved the artery extensibility and prevented the stiffening of the blood vessel, a characteristic of aging. AGE and its components also have been reported to protect the vascular endothelial cells from oxidant injury (57). Our findings and several other studies suggest that protection and maintenance of the flexibility in the blood vessel may be one mechanism for the SBP-lowering effect of AGE. However the PP of the RG group had no significant differences compared with the control group, with respect to the lowering of both the MBP and the SBP. This suggests that the SBP lowering by RG was less effective than that of AGE on the blood-vessel extensibility.
The erythrocyte, which is the main component of blood, also fulfills a major role in the blood circulatory and BP systems. Considering the longevity (
60 d) of the erythrocyte in rats, administering the garlic source for 34 wk will affect half of the erythrocytes circulating in vivo. It has been shown that AGE and its components improved the peripheral circulation (4) and the erythrocyte deformability (23). This suggests that improvement of blood circulation by AGE might be one cause for the SBP-lowering effect. However, the RG group showed a significant decrease in erythrocytes and increase in reticulocytes, which are immature erythrocytes, suggesting chronic feeding of RG powder could lead to anemia (3,24). Therefore, the SBP-lowering effect of the RG group was less effective than AGE in the improvement of blood circulation. Moreover, in addition to causing an anemic condition, the RG group also had the additional complication of a high frequency of papilloma in the forestomach and a decline of body wt. This suggests that long-term feeding of the RG produced potentially harmful side effects.
In conclusion, chronic feeding of both AGE and RG prevented the increase of SBP on the SHR rats. The effect of AGE is based on the improvement in the blood circulatory system, such as the maintenance of the blood vessel flexibility and the improvement of the erythrocyte deformability. However, the SBP lowering of RG was indicated to cause harmful effects such as anemia, the decrease in body wt and the generation of papilloma in the forestomach, and long-term feeding of RG has the danger of health damage. These results suggest that AGE more safely improves several circulatory diseases related to blood vessel than raw garlic.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Author disclosure: No relationships to disclose. ![]()
4 Abbreviations used: AGE, aged garlic extract; BP, blood pressure; MBP, mean blood pressure; PP, pulse pressure; RG, raw garlic; SBP, systolic blood pressure; SHR, spontaneously hypertensive rat. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Japanese Ministry of Health and Welfare. Annual Report (19981999), Social Security and National Life [internet report cited 2005 April 8]. Available from: http://www.mhlw.go.jp/english/wp/wp-hw/vol1/p2c6s4.html.
2. The Merck Manual of Medical Information. Hypertension [internet report cited 2005 April 8]. Available from: http://mmh.banyu.co.jp/mmhe2j/sec03/ch022/ch022a.html.
3. Nakagawa S, Masamoto K, Sumiyoshi H, Kunihiro K, Fuwa T. Effect of raw and extracted-aged garlic juice on growth of young rats and their organs after peroral administration. J Toxicol Sci. 1980;5:91112.[Medline]
4. Okuhara T. Clinical study of aged garlic extract on peripheral circulation. Jpn. Pharmacol. Theraput. 1994;22:3695701.
5. Yamasaki T, Li L, Lau BHS. Garlic compounds protect vascular endothelial cells from hydrogen peroxide-induced oxidant injury. Phytother Res. 1994;8:40812.
6. Ide N, Lau BHS. Garlic compounds protect vascular endothelial cells from oxidized low density lipoprotein-induced injury. J Pharm Pharmacol. 1997;49:90811.[Medline]
7. Wei Z, Lau BH. Garlic inhibits free radical generation and augments antioxidant enzyme activity in vascular endothelial cells. Nutr Res. 1998;18:6170.
8. Lau BHS, Lam F, Wang-Cheng R. Effect of an odor-modified garlic preparation on blood lipids. Nutr Res. 1987;7:13949.[Medline]
9. Yeh YY, Yeh SM. Garlic reduces plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesis. Lipids. 1994;29:18993.[Medline]
10. Fukuda S, Tsuchikura S, Iida H. Age-related changes in blood pressure, hematological values, concentrations of serum biochemical constituents and weights of organs in the SHR/Izm, SHRSP/Izm and WKY/Izm. Exp Anim. 2004;53:6772.[Medline]
11. Reeves PG, Neilsen FH, Fahey GC. Committee report on the AIN-93 purified rodent diet. J Nutr. 1993;123:193951.
12. Bunag RD. Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol. 1973;34:27982.
13. Mohamadi A, Jarrell ST, Shi SJ, Andrawis NS, Myers A, Clouatre D, Preuss HG. Effects of wild versus cultivated garlic on blood pressure and other parameters in hypertensive rats. Heart Dis. 2000;2:39.[Medline]
14. Steiner M, Khan AH, Holbert D, Lin RI. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr. 1996;64:86670.
15. Morihara N, Sumioka I, Moriguchi T, Uda N, Kyo E. Aged garlic extract enhances production of nitric oxide. Life Sci. 2002;71:50917.[Medline]
16. Das I, Kan NS, Sooranna SR. Potent activation of nitric oxide synthase by garlic: a basis for its therapeutic applications. Curr Med Res Opin. 1995;13:25763.[Medline]
17. Das I, Hirani J, Sooranna S. Arginine is not responsible for the activation of nitric oxide synthase by garlic. J Ethnopharmacol. 1996;53:59.[Medline]
18. Pedraza-Chaverri J, Tapia E, Medina-Campos ON, Granados MA, Franco M. Garlic prevents hypertension induced by chronic inhibition of nitric oxide synthesis. Life Sci. 1998;62:717.
19. Ignarro LJ, Buga GM, Wood KS, Byrnes RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:92659.
20. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 1989;86:33758.
21. Dart AM, Kingwell BA. Pulse pressure: a review of mechanisms and clinical relevance. J Am Coll Cardiol. 2001;37:97584.
22. Safar ME. Epidemiological findings imply that goals for drug treatment of hypertension need to be revised. Circulation. 2001;103:118890.
23. Moriguchi T, Takasugi N, Itakura Y. The effects of aged garlic extract on lipid peroxidation and the deformability of erythrocytes. J Nutr. 2001;131:1016S9S.
24. Shashikanth KN, Basappa SC, Murthy VS. Effect of feeding raw and boiled garlic (A. Sativum L.) extracts on the growth, caecal and microflora and serum proteins of albino rats. Nutr Rep Int. 1986;33:3139.
This article has been cited by other articles:
![]() |
C. Cruz, R. Correa-Rotter, D. J. Sanchez-Gonzalez, R. Hernandez-Pando, P. D. Maldonado, C. M. Martinez-Martinez, O. N. Medina-Campos, E. Tapia, D. Aguilar, Y. I. Chirino, et al. Renoprotective and antihypertensive effects of S-allylcysteine in 5/6 nephrectomized rats Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1691 - F1698. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||